Cardio-Oncology

Explore how to mitigate the effects of cancer on the heart.

Science News

Clonal Hematopoiesis and Its Cardiovascular Implications
Coronary Atherosclerosis in Patients With Cancer and Survivors
Classification and Management of Ischemic Stroke in Patients with Active Cancer
2026 Heart Disease and Stroke Statistics
Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function

Journals

Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy
Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats
Prothrombin G20210A and Factor V Leiden Variants Are Not Associated With Thrombotic Events in Congenital Heart Disease: An Observational Trial
Survival Benefit of Heart–Kidney Versus Heart Transplant With or Without Delayed Kidney Transplant
Health Equity Perspective on Data‐Driven Treatment Decisions in Cardiovascular Care: Risk Assessments Versus Individualized Treatment Rules
Erin Bohula, MD, of Brigham and Women's Hospital, Boston, Massachusetts, USA presents findings for VESALIUS-CV at Scientific Sessions 2025.
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

CEO Nancy Brown on Cardio Oncology

CEO Nancy Brown explains why the AHA is funding a Strategically Focused Research Network on cardio-oncology with $15 million and, working with CancerLinQ LLC, making oncology datasets available on a version of the Precision Medicine Platform.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership